About DENTSPLY SIRONA Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.dentsplysirona.com/
Frequently Asked Questions
What is the 52-week range for XRAY?
The 52-week high is $14.76 and the 52-week low is $8.61.
What is the P/E ratio for XRAY?
The P/E ratio data is currently unavailable.
What is the dividend yield for XRAY?
The indicated annual dividend yield is 5.50%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -39.81%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -14.99%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.70.
Analyst Recommendation Trends
Wall Street analyst consensus for XRAY over the last few months:
Latest XRAY News
Dental Implants and Prosthetics Market Forecasts Growth from $12.79B (2026) to $17.67B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & Henry Schein
The global dental implants and prosthetics market is projected to grow from USD 12.79 billion in 2026 to USD 17.67 billion by 2031, at a 6.7% CAGR. Growth is driven by rising tooth loss, an aging population, demand for cosmetic dentistry, and advances in CAD/CAM, 3D printing and minimally invasive procedures. Dental implants and dental hospitals & clinics led the market in 2025, while Europe held the largest regional share. High treatment costs, limited reimbursement and shortages of skilled den
Dental Equipment Market Forecasts Growth from $8.31B (2026) to $11.48B by 2031, Profiling Envista, Carestream Dental, Nakanishi & Dentsply Sirona
The global dental equipment market is projected to grow from USD 8.31 billion in 2026 to USD 11.48 billion by 2031, registering a 5.5% CAGR. Growth is driven by rising oral health disorders, demand for cosmetic and preventive dentistry, dental tourism, and adoption of digital imaging, CAD/CAM, intraoral scanners, laser dentistry, and 3D printing. Therapeutic dental equipment will hold the largest market share, while hospitals and clinics remain the leading end users. The US is expected to record
Dental Consumables Market Forecasts Growth from $37.0B (2026) to $54.0B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & 3M
The global dental consumables market is projected to grow from USD 37.0 billion in 2026 to USD 54.0 billion by 2031, registering a 7.9% CAGR. Growth is driven by rising dental disease prevalence, aging populations, cosmetic dentistry demand, improved access to oral care, and adoption of digital dentistry and CAD/CAM technologies. Dental restoration leads by product type, while dental hospitals and clinics hold the largest end-user share. Asia Pacific is expected to record the highest CAGR, suppo
3 Stocks Under $10 Walking a Fine Line
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Dentsply Sirona's Troubles Are Nothing To Smile About (Downgrade)
Dentsply Sirona (XRAY) stock outlook: revenue declines, weak cash flow, and 3.4x leverage despite cheap valuationâsee why itâs a soft sell.
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & technology stocks fared in Q2, starting with Dentsply Sirona (NASDAQ:XRAY).
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10
BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.
3 Russell 2000 Stocks We Steer Clear Of
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation
DENTSPLY SIRONA (XRAY) shares are in focus after the company reported second quarter 2026 results that returned the business to profitability while net sales declined 4.1% year over year. The latest results and upcoming appearance at the Baird 2026 Global Healthcare Conference come after a mixed share price pattern for DENTSPLY SIRONA, with a 7 day share price return of 3.53% but a 30 day share price return that declined 19.90%. Recent momentum has been choppy, as a 90 day share price return...
Dentsply Sirona (XRAY) Stock May Still Trade At A Discount
DENTSPLY SIRONA stock has had a difficult run over the past few years, yet on broad valuation checks it now screens as one of the cheaper options in its peer group. The share price history and the current multiples are sending very different signals about what the market expects from the business. Over the past 5 years, DENTSPLY SIRONA shareholders have seen the stock fall about 79.6%, which points to a long period of weak sentiment that still weighs on expectations today. The valuation...
Does XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis?
Dentsply Sirona recently reported second-quarter 2026 results showing a 4.1% year-over-year net sales decline but a return to net income, with higher margins and stronger cash generation, and also confirmed it will present at the Baird 2026 Global Healthcare Conference on September 15, 2026. The combination of improved profitability and cash flow, despite weaker revenue and a history of pressure on returns, led management to reiterate full-year 2026 guidance, highlighting a sharper focus on...
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare Conference. Management is scheduled to present on Tuesday, September 15, 2026, at 11:25 a.m. ET. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://inves
Dentsply Sirona (XRAY) Swings Back To Profit While Sales Keep Sliding
On August 6, Dentsply Sirona (NASDAQ:XRAY) reported second-quarter 2026 results that pulled the stock in two directions at once. Net sales fell 4.1% year over year to $898 million, yet the company swung from a $45 million net loss a year earlier to $37 million in net income, with diluted earnings per share of $0.18 […]
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 25.1% over the past six months, topping the S&P 500 by 13.1 percentage points.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-10 | Fortson John C. | +104,200 | - | - |
| 2026-08-10 | Fortson John C. | +24,014 | - | - |
| 2026-08-07 | Frohning Andrea L. | -802 | $12.12 | $9,720 |
| 2026-06-30 | MAZELSKY JONATHAN JAY | +2,842 | $10.56 | $30,012 |
| 2026-06-15 | HOSEIN CLYDE | +6,500 | $9.985 | $64,902 |
| 2026-06-15 | Gladden Brian T | +9,985 | $10.015 | $100,000 |
| 2026-06-12 | MAZELSKY JONATHAN JAY | +10,000 | $10.14 | $101,400 |
| 2026-06-12 | MCKEON BRIAN P | +10,000 | $10.12 | $101,200 |
| 2026-06-11 | Barber Michael J | +15,175 | $9.885 | $150,005 |
| 2026-06-11 | HOLDEN BETSY D | +10,086 | $9.8842 | $99,692 |
| 2026-06-03 | Barber Michael J | +22,822 | - | - |
| 2026-06-03 | Vergis Janet S. | +22,822 | - | - |
| 2026-06-03 | MAZELSKY JONATHAN JAY | +22,822 | - | - |
| 2026-06-03 | Forbes James D | +28,887 | - | - |
| 2026-06-03 | Gladden Brian T | +22,822 | - | - |
| 2026-06-03 | Zurbay Donald | +22,822 | - | - |
| 2026-06-03 | LUCIER GREGORY T | +10,900 | - | - |
| 2026-06-03 | LUCIER GREGORY T | -10,900 | - | - |
| 2026-06-03 | LUCIER GREGORY T | +10,900 | - | - |
| 2026-06-03 | LUCIER GREGORY T | +38,382 | - | - |
| 2026-06-03 | LUCIER GREGORY T | -38,382 | - | - |
| 2026-06-03 | LUCIER GREGORY T | +38,382 | - | - |
| 2026-06-03 | HOSEIN CLYDE | +22,822 | - | - |
| 2026-06-03 | MCKEON BRIAN P | +28,887 | - | - |
| 2026-06-03 | VARON LESLIE F | +22,822 | - | - |
| 2026-06-03 | HOLDEN BETSY D | +22,822 | - | - |
| 2026-05-22 | Scavilla Daniel T | -4,095 | $10.21 | $41,810 |
| 2026-03-31 | MAZELSKY JONATHAN JAY | +2,645 | $11.34 | $29,994 |
| 2026-03-11 | Denti Aldo Mariano Roberto | +829 | $11.43 | $9,475 |
| 2026-03-11 | Czerney Kevin | +2,854 | $11.43 | $32,621 |
| 2026-03-11 | Scavilla Daniel T | +3,555 | $11.43 | $40,634 |
| 2026-03-09 | Forbes James D | +5,000 | $12.48 | $62,400 |
| 2026-03-09 | LUCIER GREGORY T | +15,000 | $12.445 | $186,675 |
| 2026-03-04 | Denti Aldo Mariano Roberto | +270,200 | - | - |
| 2026-03-04 | Denti Aldo Mariano Roberto | +59,524 | - | - |
| 2026-03-04 | Czerney Kevin | +10,400 | - | - |
| 2026-03-04 | Czerney Kevin | +13,690 | - | - |
| 2026-03-04 | Johnson Robert Anthony | +202,700 | - | - |
| 2026-03-04 | Johnson Robert Anthony | +44,643 | - | - |
| 2026-03-04 | Scavilla Daniel T | +2,066,600 | - | - |
| 2026-03-04 | Scavilla Daniel T | +145,089 | - | - |
| 2026-03-04 | Frohning Andrea L. | +121,600 | - | - |
| 2026-03-04 | Frohning Andrea L. | +26,786 | - | - |
| 2026-03-04 | Czerney Kevin | -328 | $13.44 | $4,408 |
| 2026-03-04 | Johnson Robert Anthony | -1,026 | $13.44 | $13,789 |
| 2026-03-04 | Frohning Andrea L. | -690 | $13.44 | $9,274 |
| 2026-03-03 | Czerney Kevin | -1,197 | $13.3 | $15,920 |
| 2026-03-03 | Czerney Kevin | -527 | $13.3 | $7,009 |
| 2026-03-03 | Johnson Robert Anthony | -4,481 | $13.3 | $59,597 |
| 2026-03-03 | Johnson Robert Anthony | -3,229 | $13.3 | $42,946 |
| 2026-03-03 | Frohning Andrea L. | -1,977 | $13.3 | $26,294 |
| 2026-03-03 | Frohning Andrea L. | -2,990 | $13.3 | $39,767 |
| 2026-03-03 | Forbes James D | +5,000 | $13.469 | $67,345 |
| 2026-03-03 | LUCIER GREGORY T | +22,445 | $14.028 | $314,858 |
| 2026-03-02 | Johnson Robert Anthony | +9,599 | - | - |
| 2026-03-02 | Frohning Andrea L. | +8,861 | - | - |
| 2026-03-02 | LUCIER GREGORY T | +27,555 | $14.245 | $392,521 |
| 2026-03-02 | Czerney Kevin | +1,478 | - | - |
| 2026-02-24 | Scavilla Daniel T | -1,194 | $13.14 | $15,689 |
| 2026-01-26 | Zurbay Donald | +6,871 | - | - |
| 2026-01-09 | Czerney Kevin | +45 | $12.22 | $550 |
| 2026-01-09 | Czerney Kevin | +4 | $12.22 | $49 |
| 2026-01-09 | Czerney Kevin | +263 | - | - |
| 2026-01-09 | Johnson Robert Anthony | +40 | $12.22 | $489 |
| 2026-01-09 | Johnson Robert Anthony | +642 | - | - |
| 2026-01-09 | Barber Michael J | +246 | - | - |
| 2026-01-09 | Scavilla Daniel T | +246 | - | - |
| 2026-01-09 | Frohning Andrea L. | +23 | $12.22 | $281 |
| 2026-01-09 | Frohning Andrea L. | +392 | - | - |
| 2026-01-09 | Vergis Janet S. | +201 | - | - |
| 2026-01-09 | MAZELSKY JONATHAN JAY | +154 | $12.22 | $1,882 |
| 2026-01-09 | MAZELSKY JONATHAN JAY | +395 | - | - |
| 2026-01-09 | Gladden Brian T | +315 | - | - |
| 2026-01-09 | Deese Willie A | +202 | - | - |
| 2026-01-09 | LUCIER GREGORY T | +341 | - | - |
| 2026-01-09 | HOSEIN CLYDE | +355 | - | - |
| 2026-01-09 | VARON LESLIE F | +198 | - | - |
| 2026-01-09 | HOLDEN BETSY D | +711 | - | - |
| 2025-12-09 | Czerney Kevin | +96,500 | - | - |
| 2025-12-08 | LUCIER GREGORY T | -82,200 | $11.14 | $915,708 |
| 2025-11-28 | Johnson Robert Anthony | -8,737 | $11.34 | $99,078 |
| 2025-11-28 | Johnson Robert Anthony | -293 | $11.34 | $3,323 |
| 2025-11-24 | VARON LESLIE F | +9,337 | $10.71 | $99,999 |
| 2025-11-07 | Johnson Robert Anthony | +471,400 | - | - |
| 2025-11-07 | Johnson Robert Anthony | +361,700 | - | - |
| 2025-11-07 | Johnson Robert Anthony | +417,200 | - | - |
| 2025-10-14 | LUCIER GREGORY T | +17,200 | - | - |
| 2025-10-14 | LUCIER GREGORY T | -17,200 | - | - |
| 2025-10-10 | Czerney Kevin | +4 | $11.98 | $48 |
| 2025-10-10 | Czerney Kevin | +45 | $11.98 | $539 |
| 2025-10-10 | Czerney Kevin | +234 | - | - |
| 2025-10-10 | Johnson Robert Anthony | +41 | $11.98 | $491 |
| 2025-10-10 | Johnson Robert Anthony | +972 | - | - |
| 2025-10-10 | Barber Michael J | +224 | - | - |
| 2025-10-10 | GARTH MATTHEW E | +556 | - | - |
| 2025-10-10 | Scavilla Daniel T | +224 | - | - |
| 2025-10-10 | Frohning Andrea L. | +23 | $11.98 | $276 |
| 2025-10-10 | Frohning Andrea L. | +357 | - | - |
| 2025-10-10 | Vergis Janet S. | +179 | - | - |
| 2025-10-10 | MAZELSKY JONATHAN JAY | +123 | $11.98 | $1,474 |
| 2025-10-10 | MAZELSKY JONATHAN JAY | +360 | - | - |
| 2025-10-10 | Gladden Brian T | +286 | - | - |
| 2025-10-10 | Deese Willie A | +179 | - | - |
| 2025-10-10 | LUCIER GREGORY T | +310 | - | - |
| 2025-10-10 | HOSEIN CLYDE | +286 | - | - |
| 2025-10-10 | VARON LESLIE F | +179 | - | - |
| 2025-10-10 | ROSENZWEIG RICHARD C | +81 | $11.98 | $970 |
| 2025-10-10 | ROSENZWEIG RICHARD C | +766 | - | - |
| 2025-10-10 | HOLDEN BETSY D | +647 | - | - |